- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The European Commission has authorised the use of the antiviral medication remdesivir (brand name Veklury) to treat COVID-19.
The drug has already been approved for emergency use in several countries outside Europe, including Japan and the United States.
Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars
Additional data provided by
English
Japanese
